3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine

C128H131Cl4F2N27O4 — CID 161098353

About 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine

3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine (PubChem CID 161098353) has the molecular formula C128H131Cl4F2N27O4 and a molecular weight of 2291.45 g/mol. Its IUPAC name is 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine.

Molecular Properties

• Compound Name: 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine
• PubChem CID: 161098353
• Molecular Formula: C128H131Cl4F2N27O4
• Molecular Weight: 2291.45 g/mol
• Exact Mass: 2287.96
• IUPAC Name: 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine
• SMILES: CCCCN1CCC(c2nn(-c3ccc(Cl)cc3)c3cnccc23)CC1.Cc1ccc(-n2nc(C3CCOCC3)c3ccncc32)cc1.Cc1ccc(-n2nc(C3COCCN3)c3ccncc32)cc1.Clc1ccc(-n2nc(C3CCN(Cc4ccn[nH]4)CC3)c3ccncc32)cc1.Clc1ccc(-n2nc(C3CCNCC3)c3ccncc32)cc1.Fc1ccc(-n2nc(C3CCOCC3)c3ccncc32)cc1.Fc1cncc2c1c(C1CCOCC1)nn2-c1ccc(Cl)cc1
• InChI: InChI=1S/C21H21ClN6.C21H25ClN4.C18H19N3O.C17H15ClFN3O.C17H17ClN4.C17H16FN3O.C17H18N4O/c22-16-1-3-18(4-2-16)28-20-13-23-9-6-19(20)21(26-28)15-7-11-27(12-8-15)14-17-5-10-24-25-17;1-2-3-12-25-13-9-16(10-14-25)21-19-8-11-23-15-20(19)26(24-21)18-6-4-17(22)5-7-18;1-13-2-4-15(5-3-13)21-17-12-19-9-6-16(17)18(20-21)14-7-10-22-11-8-14;18-12-1-3-13(4-2-12)22-15-10-20-9-14(19)16(15)17(21-22)11-5-7-23-8-6-11;18-13-1-3-14(4-2-13)22-16-11-20-10-7-15(16)17(21-22)12-5-8-19-9-6-12;18-13-1-3-14(4-2-13)21-16-11-19-8-5-15(16)17(20-21)12-6-9-22-10-7-12;1-12-2-4-13(5-3-12)21-16-10-18-7-6-14(16)17(20-21)15-11-22-9-8-19-15/h1-6,9-10,13,15H,7-8,11-12,14H2,(H,24,25);4-8,11,15-16H,2-3,9-10,12-14H2,1H3;2-6,9,12,14H,7-8,10-11H2,1H3;1-4,9-11H,5-8H2;1-4,7,10-12,19H,5-6,8-9H2;1-5,8,11-12H,6-7,9-10H2;2-7,10,15,19H,8-9,11H2,1H3
• InChIKey: UICDWWNFZZZZIQ-UHFFFAOYSA-N
• XLogP: 26.34
• TPSA: 311.11 Ų
• H-Bond Donors: 3
• H-Bond Acceptors: 30
• Rotatable Bonds: 19
• Heavy Atoms: 165
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2291.45
LogP ≤ 5	26.34
H-Bond Donors ≤ 5	3
H-Bond Acceptors ≤ 10	30

Frequently Asked Questions

What is the IUPAC name of 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine?

The IUPAC name of 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine (CID 161098353) is 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine.

What is the SMILES notation for 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine?

The canonical SMILES for 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine is CCCCN1CCC(c2nn(-c3ccc(Cl)cc3)c3cnccc23)CC1.Cc1ccc(-n2nc(C3CCOCC3)c3ccncc32)cc1.Cc1ccc(-n2nc(C3COCCN3)c3ccncc32)cc1.Clc1ccc(-n2nc(C3CCN(Cc4ccn[nH]4)CC3)c3ccncc32)cc1.Clc1ccc(-n2nc(C3CCNCC3)c3ccncc32)cc1.Fc1ccc(-n2nc(C3CCOCC3)c3ccncc32)cc1.Fc1cncc2c1c(C1CCOCC1)nn2-c1ccc(Cl)cc1.

What is the InChIKey of 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine?

The InChIKey is UICDWWNFZZZZIQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H21ClN6.C21H25ClN4.C18H19N3O.C17H15ClFN3O.C17H17ClN4.C17H16FN3O.C17H18N4O/c22-16-1-3-18(4-2-16)28-20-13-23-9-6-19(20)21(26-28)15-7-11-27(12-8-15)14-17-5-10-24-25-17;1-2-3-12-25-13-9-16(10-14-25)21-19-8-11-23-15-20(19)26(24-21)18-6-4-17(22)5-7-18;1-13-2-4-15(5-3-13)21-17-12-19-9-6-16(17)18(20-21)14-7-10-22-11-8-14;18-12-1-3-13(4-2-12)22-15-10-20-9-14(19)16(15)17(21-22)11-5-7-23-8-6-11;18-13-1-3-14(4-2-13)22-16-11-20-10-7-15(16)17(21-22)12-5-8-19-9-6-12;18-13-1-3-14(4-2-13)21-16-11-19-8-5-15(16)17(20-21)12-6-9-22-10-7-12;1-12-2-4-13(5-3-12)21-16-10-18-7-6-14(16)17(20-21)15-11-22-9-8-19-15/h1-6,9-10,13,15H,7-8,11-12,14H2,(H,24,25);4-8,11,15-16H,2-3,9-10,12-14H2,1H3;2-6,9,12,14H,7-8,10-11H2,1H3;1-4,9-11H,5-8H2;1-4,7,10-12,19H,5-6,8-9H2;1-5,8,11-12H,6-7,9-10H2;2-7,10,15,19H,8-9,11H2,1H3.

What are the key properties of 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine?

3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine has a molecular weight of 2291.45 g/mol, XLogP of 26.34, 19 rotatable bonds, 3 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for 3-(1-butylpiperidin-4-yl)-1-(4-chlorophenyl)pyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-4-fluoro-3-(oxan-4-yl)pyrazolo[3,4-c]pyridine;1-(4-chlorophenyl)-3-piperidin-4-ylpyrazolo[5,4-c]pyridine;1-(4-chlorophenyl)-3-[1-(1H-pyrazol-5-ylmethyl)piperidin-4-yl]pyrazolo[5,4-c]pyridine;1-(4-fluorophenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;1-(4-methylphenyl)-3-(oxan-4-yl)pyrazolo[5,4-c]pyridine;3-[1-(4-methylphenyl)pyrazolo[5,4-c]pyridin-3-yl]morpholine is sourced from PubChem (CID 161098353), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).